HighCape Partners
Overview
HighCape Partners is a growth equity fund that invests in commercial-stage life sciences companies. We apply decades of combined investment and operational experience to transform our portfolio companies into sustainable businesses with multiple exit alternatives.
Investment Focus
- Innovative life sciences companies in connected health, medical devices, and biotechnology sectors
Portfolio Companies
Reach HighCape Partners directly
Verified work email, phone and LinkedIn for the full team — one spreadsheet, one payment, yours to keep.
Unlock full contacts →Frequently asked questions about HighCape Partners
What sectors does HighCape Partners invest in?
HighCape Partners invests in Healthcare, Medical Devices, Biotechnology and Connected Health, and is based in New York, New York, United States. HighCape Partners is listed as a vc in the ConnectSafely investor database.
What stage does HighCape Partners invest at?
HighCape Partners backs companies at Seed, Early Stage, Series A, Series B, Growth and Late Stage.
Which regions does HighCape Partners invest in?
HighCape Partners invests across United States.
What companies has HighCape Partners invested in?
HighCape Partners's portfolio includes Quantum-Si, TELA Bio, Wellinks, Cybrexa Therapeutics, Alphina Therapeutics, Modifi BioSciences and Aziyo Biologics.
How do I contact HighCape Partners?
HighCape Partners's contact details — including phone and LinkedIn — are listed in the ConnectSafely investor database, along with its website and the LinkedIn profiles of the team.
Last updated · Source: ConnectSafely investor database
